ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
62.48
+0.36 (0.58%)
At close: Jun 13, 2025, 4:00 PM
62.56
+0.08 (0.13%)
After-hours: Jun 13, 2025, 4:04 PM EDT
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for ANI Pharmaceuticals stock ranges from a low of $65 to a high of $94. The average analyst price target of $80.13 forecasts a 28.25% increase in the stock price over the next year.
Price Target: $80.13 (+28.25%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for ANI Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $86 | Strong Buy | Reiterates | $86 | +37.64% | May 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $62 → $65 | Hold | Maintains | $62 → $65 | +4.03% | Apr 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $86 | Strong Buy | Reiterates | $86 | +37.64% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $94 | Strong Buy | Reiterates | $94 | +50.45% | Mar 17, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +28.04% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
799.71M
from 614.38M
Increased by 30.17%
Revenue Next Year
861.19M
from 799.71M
Increased by 7.69%
EPS This Year
6.59
from -1.04
EPS Next Year
7.22
from 6.59
Increased by 9.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 836.4M | 910.9M | 995.5M | ||
| Avg | 799.7M | 861.2M | 921.0M | ||
| Low | 751.5M | 804.0M | 830.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.1% | 13.9% | 15.6% | ||
| Avg | 30.2% | 7.7% | 6.9% | ||
| Low | 22.3% | 0.5% | -3.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.94 | 8.48 | 10.43 | ||
| Avg | 6.59 | 7.22 | 8.32 | ||
| Low | 6.09 | 6.04 | 6.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 28.8% | 44.3% | ||
| Avg | - | 9.7% | 15.2% | ||
| Low | - | -8.3% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.